Пређи на садржај

WAY-100635 — разлика између измена

С Википедије, слободне енциклопедије
Садржај обрисан Садржај додат
мНема описа измене
мНема описа измене
Ред 26: Ред 26:
}}
}}


-{'''WAY-100,635'''}- je [[piperazin]]ski [[lek]] koji je u širokoj upotrebi u naučnim istraživanjima. Za njega se originalno smatralo da deluje kao selektivni [[5-HT1A|-{5-HT<sub>1A</sub>}-]] [[antagonist (farmakologija)|antagonist]], ali su naknadna istraživanja pokazala da on isto tako deluje kao potentan [[agonist (farmakologija)|pun agonist]] na [[D4 receptor|D<sub>4</sub>]] receptoru.<ref>{{Cite journal | author = C. A. Fornal, C. W. Metzler, R. A. Gallegos, S. C. Veasey, A. C. McCreary and B. L. Jacobs | title = WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135 | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 278 | issue = 2 | pages = 752&ndash;762 | year = 1996 | url = http://jpet.aspetjournals.org/cgi/content/abstract/278/2/752 | pmid = 8768728 }}</ref><ref>{{Cite journal | author = Benjamin R. Chemel, Bryan L. Roth, Blaine Armbruster, Val J. Watts and David E. Nichols | title = WAY-100635 is a potent dopamine D4 receptor agonist | journal = Psychopharmacology | month = October | volume = 188 | issue = 2 | pages = 244–251 | year = 2006 | pmid = 16915381 | url = http://www.springerlink.com/content/vt36125287348028/ | doi = 10.1007/s00213-006-0490-4}}</ref><ref name="pmid19179855">{{cite journal |author=Marona-Lewicka D, Nichols DE |title=WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation |journal=Behav Pharmacol |volume=20 |issue=1 |pages=114–8 |year=2009 |pmid=19179855 |doi=10.1097/FBP.0b013e3283242f1a |url=}}</ref> On se ponekad naziva nemim antagonistom -{5-HT1A}- receptora.<ref>{{Cite journal | author = A. Fletcher, E. A. Forster, D. J. Bill, G. Brown, I. A. Cliffe, J. E. Hartley, D. E. Jones, A. McLenachan, K. J. Stanhope, D. J. Critchley, K. J. Childs, V. C. Middlefell, L. Lanfumey, R. Corradetti, A. M. Laporte, H. Gozlan, M. Hamon & C. T. Dourish | title = Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist | journal = Behavioural Brain Research | volume = 73 | issue = 1-2 | pages = 337–333 | year = 1996 | month = | pmid = 8788530 | doi = 10.1016/0166-4328(96)00118-0 }}</ref> -{WAY-100,635}- i -{[[WAY-100,135]]}- su hemijski sličani.
-{'''WAY-100,635'''}- je [[piperazin]]ski [[lek]] koji je u širokoj upotrebi u naučnim istraživanjima. Za njega se originalno smatralo da deluje kao selektivni [[5-HT1A|-{5-HT<sub>1A</sub>}-]] [[antagonist (farmakologija)|antagonist]], ali su naknadna istraživanja pokazala da on isto tako deluje kao potentan [[agonist (farmakologija)|pun agonist]] na [[D4 receptor|D<sub>4</sub>]] receptoru.<ref>{{Cite journal | author = C. A. Fornal, C. W. Metzler, R. A. Gallegos, S. C. Veasey, A. C. McCreary and B. L. Jacobs | title = WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135 | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 278 | issue = 2 | pages = 752&ndash;762 | year = 1996 | url = http://jpet.aspetjournals.org/cgi/content/abstract/278/2/752 | pmid = 8768728 }}</ref><ref>{{Cite journal | author = Benjamin R. Chemel, Bryan L. Roth, Blaine Armbruster, Val J. Watts and David E. Nichols | title = WAY-100635 is a potent dopamine D4 receptor agonist | journal = Psychopharmacology | month = October | volume = 188 | issue = 2 | pages = 244–251 | year = 2006 | pmid = 16915381 | url = http://www.springerlink.com/content/vt36125287348028/ | doi = 10.1007/s00213-006-0490-4}}</ref><ref name="pmid19179855">{{cite journal |author=Marona-Lewicka D, Nichols DE |title=WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation |journal=Behav Pharmacol |volume=20 |issue=1 |pages=114–8 |year=2009 |pmid=19179855 |doi=10.1097/FBP.0b013e3283242f1a |url=}}</ref> On se ponekad naziva nemim antagonistom -{5-HT1A}- receptora.<ref>{{Cite journal | author = A. Fletcher, E. A. Forster, D. J. Bill, G. Brown, I. A. Cliffe, J. E. Hartley, D. E. Jones, A. McLenachan, K. J. Stanhope, D. J. Critchley, K. J. Childs, V. C. Middlefell, L. Lanfumey, R. Corradetti, A. M. Laporte, H. Gozlan, M. Hamon & C. T. Dourish | title = Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist | journal = Behavioural Brain Research | volume = 73 | issue = 1-2 | pages = 337–333 | year = 1996 | month = | pmid = 8788530 | doi = 10.1016/0166-4328(96)00118-0 }}</ref> -{WAY-100,635}- i -{[[WAY-100,135]]}- su hemijski slični.


== Reference ==
== Reference ==

Верзија на датум 10. април 2012. у 03:10

WAY-100635
IUPAC ime
N-[2-[4-(2-metoksifenil)-1-piperazinil]etil]- N-(2-piridil)cikloheksankarboksamid
Identifikatori
CAS broj146714-97-8 ДаY
ATC kodnone
PubChemCID 5684
IUPHAR/BPS80
ChEMBLCHEMBL31354 ДаY
Hemijski podaci
FormulaC25H34N4O2
Molarna masa422,56 g/mol

WAY-100,635 je piperazinski lek koji je u širokoj upotrebi u naučnim istraživanjima. Za njega se originalno smatralo da deluje kao selektivni 5-HT1A antagonist, ali su naknadna istraživanja pokazala da on isto tako deluje kao potentan pun agonist na D4 receptoru.[1][2][3] On se ponekad naziva nemim antagonistom 5-HT1A receptora.[4] WAY-100,635 i WAY-100,135 su hemijski slični.

Reference

  1. ^ C. A. Fornal, C. W. Metzler, R. A. Gallegos, S. C. Veasey, A. C. McCreary and B. L. Jacobs (1996). „WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135”. The Journal of Pharmacology and Experimental Therapeutics. 278 (2): 752–762. PMID 8768728. 
  2. ^ Benjamin R. Chemel, Bryan L. Roth, Blaine Armbruster, Val J. Watts and David E. Nichols (2006). „WAY-100635 is a potent dopamine D4 receptor agonist”. Psychopharmacology. 188 (2): 244—251. PMID 16915381. doi:10.1007/s00213-006-0490-4.  Непознати параметар |month= игнорисан (помоћ)
  3. ^ Marona-Lewicka D, Nichols DE (2009). „WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation”. Behav Pharmacol. 20 (1): 114—8. PMID 19179855. doi:10.1097/FBP.0b013e3283242f1a. 
  4. ^ A. Fletcher, E. A. Forster, D. J. Bill, G. Brown, I. A. Cliffe, J. E. Hartley, D. E. Jones, A. McLenachan, K. J. Stanhope, D. J. Critchley, K. J. Childs, V. C. Middlefell, L. Lanfumey, R. Corradetti, A. M. Laporte, H. Gozlan, M. Hamon & C. T. Dourish (1996). „Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist”. Behavioural Brain Research. 73 (1-2): 337—333. PMID 8788530. doi:10.1016/0166-4328(96)00118-0. 

Spoljašnje veze